Ez-PAVE: Initial Statin-Ezetimibe Combination No Better than Statins Alone
Image supplied with the source report: Hcplive.

With LDL-C target-guided titration, starting statin plus ezetimibe vs a statin alone yielded similar 3-year events in ASCVD.

Source disclosure

This is a source-linked briefing. Read the original report from Hcplive .

Science us Hcplive